SCHEMBL30145012

SCHEMBL30145012

CSC1=N/C(=C\c2ccc3nc(C)sc3c2)C(=O)N1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.56
▸ GAA P10253 1/20 0.56
▸ DYRK1A Q13627 11/20 0.54
▸ DYRK1B Q9Y463 11/20 0.54
▸ DYRK3 O43781 9/20 0.54
▸ DYRK2 Q92630 9/20 0.54
▸ PIM1 P11309 3/20 0.54
▸ CSNK2A2 P19784 3/20 0.54
▸ CSNK2B P67870 3/20 0.54
▸ CSNK2A1 P68400 3/20 0.54
▸ CSNK2A3 Q8NEV1 3/20 0.54
▸ HPGD P15428 2/20 0.53
▸ CLK1 P49759 8/20 0.48
▸ CLK4 Q9HAZ1 8/20 0.48
▸ CLK2 P49760 6/20 0.48
▸ CLK3 P49761 3/20 0.48
▸ KDM4E B2RXH2 2/20 0.47
▸ CNR1 P21554 1/20 0.44
▸ CNR2 P34972 1/20 0.44
▸ GPR18 Q14330 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23987070 1.00 MAPT (0.56) MAPTGAADYRK1ADYRK1BDYRK3
SCHEMBL30145008 0.88 KDM4E (0.58) MAPTGAADYRK1ADYRK1BDYRK3
SCHEMBL28945547 0.88 KDM4E (0.58) MAPTGAADYRK1ADYRK1BDYRK3
SCHEMBL25590187 0.87 CLK1 (0.52) MAPTGAADYRK1ADYRK1BDYRK3
SCHEMBL30144962 0.80 CLK1 (0.60) MAPTGAADYRK1ADYRK1BDYRK3
SCHEMBL23970084 0.80 CLK1 (0.60) MAPTGAADYRK1ADYRK1BDYRK3
SCHEMBL26092928 0.77 MAPT (0.62) MAPTGAADYRK1ADYRK1BDYRK3
SCHEMBL30363453 0.77 MAPT (0.62) MAPTGAADYRK1ADYRK1BDYRK3
SCHEMBL26096202 0.76 MAPT (0.58) MAPTGAADYRK1ADYRK1BDYRK3
SCHEMBL30275506 0.76 CLK1 (0.51) MAPTGAADYRK1ADYRK1BDYRK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143185-A1 NEW IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2023-03-08 — — EP disclosed
CN-115515953-A Novel imidazolidinone derivatives as inhibitors of protein kinases, in particular DYRK1A, CLK1 and/or CLK4 珀哈制药公司 2022-12-23 — — CN disclosed
Send feedback